SCHEMBL4369646

SCHEMBL4369646

CC(N)Cn1ncnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3225931 1.00
Hydrochloric Acid SCHEMBL2829168 0.98 LTA4H (0.32)
SCHEMBL4681957 0.82
SCHEMBL21111099 0.75 CYP19A1 (0.34)
SCHEMBL503133 0.72 GRIA1 (0.41)
SCHEMBL473559 0.72
SCHEMBL473425 0.72
SCHEMBL3998238 0.72
Hydrochloric Acid SCHEMBL21722445 0.70 HTR2A (0.34)
Hydrochloric Acid SCHEMBL3065560 0.70 HTR2A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101626686-A 3-substituent-1, 2, 3-benzotriazinone compounds for improving glutaminic synaptic responses CORTEX PHARMA INC 2010-01-13 CN disclosed
EP-2114158-A1 3-SUBSTITUTED-[1,2,3]BENZOTRIAZINONE COMPOUNDS FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES CORTEX PHARMACEUTICALS, INC. (US) 2009-11-11 EP disclosed
WO-2008085505-A1 3-SUBSTITUTED-[1,2,3]BENZOTRIAZINONE COMPOUNDS FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES CORTEX PHARMACEUTICALS, INC. (US) 2008-07-17 WO disclosed